PharVision Advisers’s Leonardo DRS DRS Stock Holding History

PharVision Advisers’s Portfolio DRS Stock Details DRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,693	Closed	-$433K	–	262
2025 Q4	$433K	Buy	+12,693	New	+$468K	0.22%	90

Other funds holding DRS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

PharVision Advisers's DRS Position: Q1 2026 in Review

PharVision Advisers sold out of Leonardo DRS (DRS) in Q1 2026, closing a stake of 12,693 shares — an estimated $433K sold.

PharVision Advisers first reported a position in DRS in Q4 2025 and held it in 1 quarter. The position peaked at $433K in Q4 2025. 344 funds tracked by Wall St. Rank hold DRS as of Q1 2026.

PharVision Advisers reported no remaining Leonardo DRS position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 12,693 Leonardo DRS shares in Q1 2026, an estimated $433K.
PharVision Advisers first reported a position in Leonardo DRS in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Leonardo DRS position peaked at $433K in Q4 2025.
344 funds tracked by Wall St. Rank held Leonardo DRS as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.